Gilead Sciences’ Statement on Remdesivir
Press Release
LANGUAGES
English
اردو
About Us
History
Company Profile
Vision, Mission & Values
Message From CEO
Board of Directors
Contact Us
Partnerships
Product Portfolio
Pharmaceuticals
Medical Technologies
Exports
Investors
Company Profile
Governance
Board of Directors
Shareholding Pattern
Name of Auditor & Legal Advisor
Investor Relations
Online Form & Contact Person
Notices of General Meetings, Dividend / Bonus Declarations
Sitemap
Search
Media
Awards
Memberships
News & Updates
Website Last Updated
Election of Directors
Notice of Election of Directors
Detail of Submitted Proxies
Profile of Contesting Candidates
List of Shareholders
Proxy Form
Ballot Paper
Investor Information
PSX Symbol
Financial Ratios
Share Registrar
Free Float
Code of Conduct
Shareholding Information
List of Non CNIC Shareholders
List of Unclaimed Dividends And Shares
Share Price
Financial Statements
Annual Reports
Interim Accounts
Financial Reports
Compliance Certificate
EHS Policy
Patients
Disease Info
Drug Safety
Send Query
Physicians
CSR
Press & Media
Videos
Home
Product
March 6, 2021
Therapeutic: HEPATOLOGY
Savera Tablets
Tuesday, 06 February 2018
by
Faraz
Ferozsons Laboratories Limited
Read more
No Comments
Xolox Capsules
Tuesday, 06 February 2018
by
Faraz
BF Biosciences
Read more
No Comments
INF 3 MIU and 5 miu
Tuesday, 06 February 2018
by
Faraz
BF Biosciences
Read more
No Comments
Novapressin
Tuesday, 06 February 2018
by
Faraz
BF Biosciences
Read more
No Comments
Peg-INF
Tuesday, 06 February 2018
by
Faraz
BF Biosciences
Read more
No Comments
Centaurus Tablets
Tuesday, 06 February 2018
by
Faraz
BF Biosciences Limited
Read more
No Comments
Viread Tablets
Tuesday, 06 February 2018
by
Faraz
Gilead
Read more
No Comments
Sovaldi Tablets
Tuesday, 06 February 2018
by
Faraz
Gilead
Read more
No Comments
TOP